1. |
van Geffen WH, Kerstjens HA. Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1269-1277.
|
2. |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med, 2017, 195(5): 557-582.
|
3. |
Wedzicha JA, Brill SE, Allinson JP, et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med, 2013, 11: 181-190.
|
4. |
Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med, 2008, 359(22): 2355-2365.
|
5. |
Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax, 2012, 67(5): 456-463.
|
6. |
Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 2002, 347(7): 465-471.
|
7. |
慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版). 国际呼吸杂志, 2014, 34(1): 1-11.
|
8. |
Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax, 1992, 47(1): 25-29.
|
9. |
Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res, 2013, 41(Database issue): D590-D596.
|
10. |
Lederberg J. Biological warfare. Emerg Infect Dis, 2001, 7(6): 1071-1072.
|
11. |
Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science, 2006, 312(5778): 1355-1359.
|
12. |
Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PloS One, 2010, 5(1): e8578.
|
13. |
Hansel TT, Johnston SL, Openshaw PJ. Microbes and mucosal immune responses in asthma. Lancet, 2013, 381(9869): 861-873.
|
14. |
Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol, 2014, 14(12): 827-835.
|
15. |
Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis, 2014, 33(7): 1101-1111.
|
16. |
Rangelov K, Sethi S. Role of infections. Clin Chest Med, 2014, 35(1): 87-100.
|
17. |
李乃健, 李冰, 冉丕鑫. 大气颗粒物对肺部微生态的影响及在慢性阻塞性肺疾病发病中的作用. 中国呼吸与危重监护杂志, 2018, 17(2): 206-209.
|
18. |
Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med, 2011, 184(8): 957-963.
|
19. |
Wang Z, Bafadhel M, Haldar K, et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J, 2016, 47(4): 1082-1092.
|
20. |
Sze MA, Dimitriu PA, Suzuki M, et al. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2015, 192(4): 438-445.
|
21. |
Galiana A, Aguirre E, Rodriguez JC, et al. Sputum microbiota in moderate versus severe patients with COPD. Eur Respir J, 2014, 43(6): 1787-1790.
|
22. |
Pragman AA, Lyu T, Baller JA, et al. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome, 2018, 6(1): 7.
|
23. |
Huang YJ, Nelson CE, Brodie EL, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol, 2011, 127(2): 372-373.
|
24. |
Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol, 2014, 52(8): 2813-2823.
|